Implication of VEGFR2 Polymorphism on the Prognosis of Anlotinib Monotherapy for Patients with Treatment-Refractory Advanced NSCLC: an Exploratory Study
Technology in Cancer Research & Treatment（2022）
关键词
nonsmall cell lung cancer,VEGFR2,polymorphism,anlotinib,biomarker
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要